KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Incyte (INCY) EBT (2016 - 2025)

Historic EBT for Incyte (INCY) over the last 16 years, with Q3 2025 value amounting to $482.3 million.

  • Incyte's EBT rose 20813.68% to $482.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 billion, marking a year-over-year increase of 47993.95%. This contributed to the annual value of $316.6 million for FY2024, which is 6204.46% down from last year.
  • As of Q3 2025, Incyte's EBT stood at $482.3 million, which was up 20813.68% from $558.0 million recorded in Q2 2025.
  • Incyte's 5-year EBT high stood at $558.0 million for Q2 2025, and its period low was -$389.8 million during Q2 2024.
  • For the 5-year period, Incyte's EBT averaged around $185.5 million, with its median value being $209.5 million (2021).
  • In the last 5 years, Incyte's EBT skyrocketed by 607118.02% in 2021 and then tumbled by 24040.76% in 2024.
  • Incyte's EBT (Quarter) stood at $120.0 million in 2021, then crashed by 32.83% to $80.6 million in 2022, then skyrocketed by 236.11% to $271.0 million in 2023, then grew by 15.78% to $313.7 million in 2024, then skyrocketed by 53.74% to $482.3 million in 2025.
  • Its EBT was $482.3 million in Q3 2025, compared to $558.0 million in Q2 2025 and $234.2 million in Q1 2025.